FrederickPearsonSmithMD

Oncology • Chevy Chase, MD

Breast Cancer, Hematologic Oncology, Thoracic Cancer

Associate Professor, Medicine, Georgetown University School of Medicine

Join to view full profile

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Smith's full profile

Already have an account?

Office
5454 Wisconsin Ave
Ste 1300
Chevy Chase, MD 20815
Phone+1 301-657-4588

Fax+1 301-657-9565

Education & Training

Georgetown University HospitalFellowship, Medical Oncology, 1976 - 1977
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1973 - 1976
Saint Louis University School of MedicineClass of 1973

Certifications & Licensure

MD State Medical License 1986 - 2025
DC State Medical License 1979 - 2024
NJ State Medical License 2015 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top Doctors:Washington DC Area Castle Connolly, 2012
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2003 Jun 01
Completed
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects wi...
Sara A. Hurvitz, Linda D. Bosserman, David Chan, Christopher T Hagenstad, Frederick C Kass
Springerplus. 2014-05-12
57 citations
Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer.
Angela Katz, Irene Gage, Sheila Evans, Margaret Shaffer, Thomas Fleury
American Journal of Surgery. 2006-06-01
20 citations
Can axillary dissection be avoided in patients with sentinel lymph node metastasis
Angela Katz, Andrzej Niemierko, Irene Gage, Sheila Evans, Margaret Shaffer
Journal of Surgical Oncology. 2006-06-01

Press Mentions

New Threats of Cancer Discussed at International MootMarch 9th, 2019
Experts Warn of New Threats of Cancer at International MootMarch 9th, 2019